I How relevant are accounting cash flows in private biotech companies? In revenue-generating firms, decisions can often be guided by accounting metrics. For example, measures like ROIC or ROCE help assess performance. But biotech is different. Many biotech companies don’t…
How cooking led to evolution – Insights from hunter gatherer societies If given the opportunity to Time Travel and envision life 20,000 years ago, we would encounter a scenario where securing sustenance posed a constant challenge. Imagine stumbling upon an…
Can you value a biotech asset based on how much money you’ve spent developing it? By that logic, what would be the value of Nokia today if we simply considered its historic investment? Not very insightful, right? 💡 The key…
If your biotech is in Phase I/II, you likely need more capital to run your programs. One way to secure non-dilutive funding is through partnerships or co-development deals with large pharma companies. ⚠️ But there’s a catch: giving away too…
Assessing whether to invest in therapeutic companies poses a challenge, particularly due to the limited historical data available—either non-existent or insufficient for a thorough evaluation. Unlike revenue-generating companies, which benefit from parameters like ROIC to gauge capital reinvestment, therapeutic companies…
Short video of our event: Snippets of an intellectually challenging discussion of our event Managing complexity and value creation in Life Sciences organised on 29th November of 2022. Farmantra would like to thank everyone that attended our event for having…
30th April 2020 We, at Farmantra, provide CFO services for young biotech/medtech companies where we focus more on decision making and managing risks and uncertainties in addition to classic finance controlling. This video illustrates the quality of our thoughts that…
21st November 2019 Farmantra successfully hosted its third annual event in the heart of Barcelona where several decision makers – CEOs, CSOs of biotech/medtech companies and others attended the event and enjoyed high quality discussions with the panelists Stephan Christgau…